ARENTFOX SCHIFF LLP

Supplemental Nutrition Assistance Program generally Medicaid program reforms, including telemedicine and prior authorization issues Section 340B Drug Pricing program Drug pricing reforms generally Juvenile mental and behavioral health legislation generally "Food as medicine" nutrition programs generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Medicare "site neutral" payment policy generally Pediatric cancer research generally Pediatric access to cell and gene therapies generally National Institutes of Health program reforms generally Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.

H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, Centers for Disease Control, and other programs related to pediatric health care Funding for cell and gene therapy generally Fiscal Year 2025 and 2026 Department of Health and Human Services funding, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, Centers for Disease Control, and other programs related to pediatric health care